Timothy Schmid - Feb 13, 2024 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, WW Chair, MedTech
Signature
Raavi Deol, as attorney-in-fact for Timothy Schmid
Stock symbol
JNJ
Transactions as of
Feb 13, 2024
Transactions value $
-$39,463
Form type
4
Date filed
2/15/2024, 04:53 PM
Previous filing
Feb 14, 2024
Next filing
Feb 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $0 +499 +3.9% $0.00 13.3K Feb 13, 2024 Direct F1
transaction JNJ Common Stock Tax liability -$39.5K -250 -1.88% $157.85 13K Feb 13, 2024 Direct F2
holding JNJ Common Stock 700 Feb 13, 2024 By 401k F3
holding JNJ Common Stock 46 Feb 13, 2024 By ESOP F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Restricted Share Units Options Exercise $0 -499 -33.33% $0.00 998 Feb 13, 2024 Common Stock 499 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.
F2 Shares withheld for payment of taxes upon vesting of Restricted Share Units.
F3 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024).
F4 Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024).